EXHIBIT 11.1
GENERAL SURGICAL INOVATIONS, INC. AND SUBSIDIARY
COMPUTATION OF NET LOSS PER SHARE (1) (2)
(in thousands, except per share data)
Three Months Ended
September 30,
------------------
1997 1996
-------- --------
Primarily and Fully Diluted:
Weighted average common shares...................... 13,314 13,147
-------- --------
Shares used in per share calculation................... 13,314 13,147
-------- --------
-------- --------
Net loss............................................... $(1,260) $ (229)
-------- --------
-------- --------
Net loss per share..................................... $ (0.09) $ (0.02)
-------- --------
-------- --------
- ---------------
(1) There is no difference between primary and fully diluted net loss per
share for all periods presented.
(2) This schedule contains summary financial information extracted from the
consolidated balance sheets and consolidated statements of operations
found on pages 3 and 4 of the Company's Form 10-Q for the year-to-date,
and is qualified in its entirety by reference to such financial statements.
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
CONSOLIDATED BALANCE SHEETS AND CONSOLIDATED STATEMENTS OF OPERATIONS FOUND ON
PAGES 3 AND 4 OF THE COMPANY'S FORM 10-Q FOR THE YEAR-TO-DATE, AND IS QUALIFIED
IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.